Skip to main content
Bacteria plus immunotherapy shows promise in prostate cancer treatment

A bacterial strain combined with immunotherapy doubled the median overall survival of mice with prostate cancer, according to a Northwestern University study published in the journal Nature Communications. The bacteria, named CP1, was isolated from a patient with benign prostate pain.

Full Story: